e- Case Report
Response to Omalizumab in Solar Urticaria: Report of 3 Cases
Respuesta a omalizumab en 3 casos de urticaria solar
P. Rodríguez-Jiménez
, P. Chicharro, A. Pérez-Plaza, D. de Argila
Autor para correspondencia
Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, Spain
Leído
6366
Vecesse ha leído el artículo
2134
Total PDF
4232
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 29 | 4 | 33 |
| 2025 5 | 161 | 37 | 198 |
| 2025 4 | 129 | 30 | 159 |
| 2025 3 | 110 | 19 | 129 |
| 2025 2 | 136 | 33 | 169 |
| 2025 1 | 95 | 28 | 123 |
| 2024 12 | 81 | 31 | 112 |
| 2024 11 | 100 | 50 | 150 |
| 2024 10 | 86 | 49 | 135 |
| 2024 9 | 85 | 27 | 112 |
| 2024 8 | 116 | 50 | 166 |
| 2024 7 | 101 | 29 | 130 |
| 2024 6 | 118 | 37 | 155 |
| 2024 5 | 65 | 31 | 96 |
| 2024 4 | 82 | 31 | 113 |
| 2024 3 | 77 | 25 | 102 |
| 2024 2 | 47 | 26 | 73 |
| 2024 1 | 55 | 41 | 96 |
| 2023 12 | 49 | 22 | 71 |
| 2023 11 | 77 | 29 | 106 |
| 2023 10 | 61 | 26 | 87 |
| 2023 9 | 75 | 30 | 105 |
| 2023 8 | 28 | 21 | 49 |
| 2023 7 | 67 | 39 | 106 |
| 2023 6 | 39 | 21 | 60 |
| 2023 5 | 51 | 25 | 76 |
| 2023 4 | 64 | 14 | 78 |
| 2023 3 | 47 | 17 | 64 |
| 2023 2 | 56 | 21 | 77 |
| 2022 1 | 44 | 24 | 68 |
| 2022 12 | 61 | 44 | 105 |
| 2022 11 | 31 | 25 | 56 |
| 2022 10 | 19 | 14 | 33 |
| 2022 9 | 27 | 45 | 72 |
| 2022 8 | 33 | 38 | 71 |
| 2022 7 | 25 | 45 | 70 |
| 2022 6 | 27 | 20 | 47 |
| 2022 5 | 42 | 42 | 84 |
| 2022 4 | 63 | 35 | 98 |
| 2022 3 | 61 | 63 | 124 |
| 2022 2 | 37 | 51 | 88 |
| 2021 1 | 50 | 34 | 84 |
| 2021 12 | 33 | 36 | 69 |
| 2021 11 | 37 | 51 | 88 |
| 2021 10 | 54 | 59 | 113 |
| 2021 9 | 31 | 38 | 69 |
| 2021 8 | 57 | 52 | 109 |
| 2021 7 | 41 | 32 | 73 |
| 2021 6 | 54 | 30 | 84 |
| 2021 5 | 49 | 45 | 94 |
| 2021 4 | 95 | 56 | 151 |
| 2021 3 | 75 | 33 | 108 |
| 2021 2 | 69 | 30 | 99 |
| 2020 1 | 48 | 27 | 75 |
| 2020 12 | 64 | 25 | 89 |
| 2020 11 | 34 | 17 | 51 |
| 2020 10 | 51 | 11 | 62 |
| 2020 9 | 50 | 20 | 70 |
| 2020 8 | 39 | 28 | 67 |
| 2020 7 | 38 | 18 | 56 |
| 2020 6 | 49 | 35 | 84 |
| 2020 5 | 25 | 21 | 46 |
| 2020 4 | 31 | 14 | 45 |
| 2020 3 | 32 | 13 | 45 |
| 2020 2 | 7 | 0 | 7 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 8 | 0 | 8 |
| 2019 11 | 2 | 0 | 2 |
| 2019 9 | 8 | 0 | 8 |
| 2019 8 | 6 | 0 | 6 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 7 | 0 | 7 |
| 2019 5 | 3 | 1 | 4 |
| 2019 4 | 4 | 0 | 4 |
| 2019 3 | 4 | 0 | 4 |
| 2019 2 | 2 | 0 | 2 |
| 2019 1 | 5 | 0 | 5 |
| 2018 12 | 3 | 0 | 3 |
| 2018 11 | 2 | 0 | 2 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 3 | 0 | 3 |
| 2018 8 | 1 | 0 | 1 |
| 2018 2 | 24 | 5 | 29 |
| 2018 1 | 38 | 7 | 45 |
| 2017 12 | 50 | 14 | 64 |
| 2017 11 | 46 | 11 | 57 |
| 2017 10 | 131 | 54 | 185 |
| 2017 9 | 1 | 17 | 18 |
| 2017 8 | 3 | 11 | 14 |
Mostrar todo
